CB

Cyril Bobby Thomas

Director Additional Director DIN 02751808
DIN 02751808 First appointment Nov 2009 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Cyril Bobby Thomas

Data last updated:

Cyril Bobby Thomas was an Additional Director at Ave Health Care Private Limited (2009–2011) and Whole-Time Director at 4S Pharma Solutions Private Limited (from 2009). The companies operate in Trading.

DIN 02751808
Primary Designation Additional Director
Industry Trading
First Appointment 15 Nov 2009
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ave Health Care Private Limited U24239KL2003PTC016619
Additional Director26 Nov 20092003₹18.4 Lakh (FY 2017)Active
4S Pharma Solutions Private Limited U33112TN2008PTC070050
Whole-Time Director15 Nov 20092008₹6.5 Lakh (FY 2015)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
4S Pharma Solutions Private Limited
Ave Health Care Private Limited
Premium access

Shareholding and investment profile for Cyril Bobby Thomas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cyril Bobby Thomas

Cyril Bobby Thomas was first appointed on 15 Nov 2009 as Whole-Time Director at 4S Pharma Solutions Private Limited.

Cyril Bobby Thomas held 2 earlier board appointments: Ave Health Care Private Limited (Additional Director, 26 Nov 2009 to 11 Nov 2011); 4S Pharma Solutions Private Limited (Whole-Time Director, from 15 Nov 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available